Kyverna Therapeutics announces licence agreement with NIH

This next-generation CAR T construct was designed to improve the tolerability profile of conventional CD19 CAR Ts and developed in the laboratory of James N. Kochenderfer, M.D., at the National Cancer Institute, part of the NIH, the same laboratory that discovered axicabtagene ciloleucel

Quidel’s Antigen tests can detect Omicron variant

The QuickVue antigen tests are able to detect the live Omicron variant with similar performance as with other variants

Siemens Healthineers receive EUA for Covid-19 antigen self-test

Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of Covid-19 exposure

Sanofi loses appeal in the US over Lantus device patents

Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee

Translumina to set up Asia's largest heart valve facility at AMTZ Vizag

The facility at the Andhra Pradesh Medtech Zone is expected to be completed by Dec 2022

U.S. FDA grants De Novo Clearance for Philips IVC filter removal laser sheath

Philips’s CavaClear is intended to safely ablate tissue to remove embedded IVC filters

U.S. FDA approves Novartis Leqvio to lower cholestrol

With two maintenance doses a year, Leqvio is the first and only FDA-approved small interfering RNA (siRNA) therapy for LDL-C (bad cholesterol) reduction1

A 39-year-old patient with Covid-19 was saved with ECMO support

Patient with acute Covid-19 infection treated at BGS Gleneagles Global Hospital

Astra Zeneca’s antibody combination to prevent Covid-19 neutralises Omicron variant

The study was performed independently by investigators at the US Food and Drug Administration (FDA), Center for Biologics Evaluation and Research

Six benefits of Cloud Computing in the pharma industry